January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Prothena Biosciences Inc
Prothena is a clinical-stage biotechnology company with expertise in protein dysregulation and a diverse pipeline of novel investigational therapies for neurodegenerative and rare peripheral amyloid diseases.